Incyte Corporation – Filings and Transcripts

NASDAQ: INCY
Share price (8/21/26): $127.81
Market cap (8/21/26): $25.9 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/26 Q2

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

Prospectuses and Registrations Filter

Registration of securities for employees

Registration of securities for employees

Registration of securities for employees

Automatic shelf registration

Issuer tender offer – amended

Ownership Filter

Cagnoni Pablo J

Cagnoni Pablo J

Cagnoni Pablo J

Cagnoni Pablo J

Mayes Patrick A

News Filter

Reports Second Quarter 2026 Financial Results and Provides Business Updates

Completes Acquisition of Vega Therapeutics, a Wholly Owned Subsidiary of Star Therapeutics, Expanding Its Hematology Portfolio

Shareholder Vote Results

To Acquire Vega Therapeutics, a Wholly Owned Subsidiary of Star Therapeutics, Expanding Its Hematology Portfolio Into Bleeding Disorders

Proxies Filter

Additional info about upcoming vote

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

Scanned paper annual report submission

Scanned paper annual report submission

Scanned paper annual report submission

Scanned paper annual report submission

Letter from the SEC